1Minic S,Obradovic M,Kovacevic 1,et al.Ocular anomalies in incontinentia pigmenti:literature review and meta-analysis[J].Srp Arh Celok Lek,2010,138(7-8):408-413.
2O'Doherty M,Mc Creery K,Green AJ,et al.Incontinentia pigmenti--ophthalmological observation of a series of cases and review of the literature[J].Br J Ophthalmol,2011,95 (1):11-16.
3Fusco F,Paciolla M,Pescatore A,et al.Microdeletion/ duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/ IKKgamma exon4_ 10 deletion in families with incontinentia pigmenti[J].Hum Mutat,2009,30(9):1284-1291.
4Ranchod TM,Trese MT.Regression of retinal neovascularization after laser photocoagulation in incontinentia pigmenti[J].Retina,2010,30(4):708-709.
5Rahi J,Hungerford J.Early diagnosis of the retinopathy of incontinentia pigmenti:successful treatment by cryotherapy[J].Br J Ophthalmol,1990,74(6):377-379.
6Mintz-Hitmer HA,Kennedy KA,Chuang AZ,et al.Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity[J].NEnglJ Med,2011,364(7):603-615.
7Wu WC,Kuo HK,Yeh PT,et al.An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan[J].Am J Ophthalmol,2013,155(1):150-158.
8Lin KL,Hirose T,Kroll AJ,et al.Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition[J].Semin Ophthalmol,2009,24(2):70-76.
